Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount  |
|---|---|---|---|---|---|---|
| BNP Paribas S.A. | BNP Paribas | financial services | economic sanction violation | 2015 | DOJ_CRIMINAL | $8,973,600,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
| BNP Paribas S.A. | BNP Paribas | financial services | economic sanction violation | 2014 | NY-MANDA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,243,400,000 |
| Credit Suisse AG | UBS | financial services | tax violations | 2014 | DOJ_TAX | $1,800,000,000 |
| JPMorgan Chase Bank | JPMorgan Chase | financial services | anti-money-laundering deficiencies | 2014 | USAO | $1,700,000,000 |
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
| Merck, Sharp & Dohme | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
| UBS AG | UBS | financial services | tax violations | 2009 | DOJ_TAX | $780,000,000 |
| Lafarge S.A. | Holcim Group | building materials | payment to designated terrorist organization | 2022 | USAO | $777,780,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
| Societe Generale S.A. | Societe Generale | financial services | economic sanction violation | 2018 | USAO | $717,200,000 |
| Adelphia Communications Corporation | accounting fraud or deficiencies | 2005 | DOJ_CRIMINAL | $715,000,000 | ||
| Commerzbank AG | Commerzbank | financial services | economic sanction violation | 2015 | DOJ_CRIMINAL | $642,000,000 |
| British American Tobacco | British American Tobacco | tobacco | economic sanction violation | 2023 | DOJ_NATSEC | $629,000,000 |
| ING Bank N.V. | ING | financial services | economic sanction violation | 2012 | DOJ_CRIMINAL | $619,000,000 |
| Bank Hapoalim B.M. and Bank Hapoalim (Switzerland) Ltd. | Bank Hapoalim | financial services | tax violations | 2020 | DOJ_TAX | $616,910,000 |
| Boeing Company | Boeing | aerospace and military contracting | False Claims Act and related | 2006 | DOJ_CIVIL | $615,000,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
| Western Union Company | Western Union | financial services | anti-money-laundering deficiencies | 2017 | DOJ_CRIMINAL | $586,000,000 |
| Republic New York Securities | HSBC | financial services | fraud | 2001 | USAO | $569,000,000 |
| Deutsche Bank AG | Deutsche Bank | financial services | tax violations | 2010 | USAO | $553,633,153 |
| Bank Julius Baer & Co. Ltd. | Julius Baer Group | financial services | tax violations | 2016 | DOJ_TAX | $547,000,000 |
| Science Applications International Corporation | Science Applications International Corp. (SAIC) | information technology | fraud | 2012 | USAO | $500,392,977 |
| AU Optronics Corporation | AU Optronics | electrical and electronic equipment | price-fixing or anti-competitive practices | 2012 | DOJ_ANTITRUST | $500,000,000 |
| ABN AMRO Bank N.V. renamed the Royal Bank of Scotland N.V. | ABN AMRO | financial services | economic sanction violation | 2010 | DOJ_CRIMINAL | $500,000,000 |
| Google Inc. | Alphabet Inc. | information technology | off-label or unapproved promotion of medical products | 2011 | FDA | $500,000,000 |
| Wyeth Pharmaceuticals Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
| Yazaki Corporation | Yazaki | automotive parts | price-fixing or anti-competitive practices | 2012 | DOJ_ANTITRUST | $470,000,000 |
| Berkeley Premium Nutraceuticals | fraud | 2008 | USAO | $459,540,000 | ||
| Bechtel Infrastructure Corp. and PB Americas Inc | Bechtel | construction and engineering | False Claims Act and related | 2008 | DOJ_CIVIL | $458,000,000 |
| KPMG LLP | KPMG | business services | tax violations | 2005 | DOJ_TAX | $456,000,000 |
| U.S. Bancorp | U.S. Bancorp | financial services | anti-money-laundering deficiencies | 2018 | USAO | $453,000,000 |
| ZTE Corporation | ZTE | telecommunications | export control violation | 2017 | DOJ_NATSEC | $430,488,798 |
| Bridgestone Corp. | Bridgestone | automotive parts | price-fixing or anti-competitive practices | 2014 | DOJ_ANTITRUST | $425,000,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $422,500,000 |
| UniCredit Group | UniCredit | financial services | economic sanction violation | 2019 | DOJ_CRIMINAL | $413,536,632 |
| Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | USAO | $410,000,000 |
| Bechtel/Parsons Brinckerhoff, Bechtel Infrastructure Corp. and PB Americas Inc. | fraud | 2008 | USAO | $407,000,000 | ||
| LG Display Co. Ltd. | LG | diversified | price-fixing or anti-competitive practices | 2008 | DOJ_ANTITRUST | $400,000,000 |
| Rabobank National Association | Rabobank | financial services | anti-money-laundering deficiencies | 2018 | DOJ_CRIMINAL | $368,701,259 |
| Kolon Industries Inc. | Kolon Industries | chemicals | price-fixing or anti-competitive practices | 2015 | DOJ_CRIMINAL | $360,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
| Air France-KLM | Air France-KLM | airlines | price-fixing or anti-competitive practices | 2008 | DOJ_ANTITRUST | $350,000,000 |
| BAWAG P.S.K. | fraud | 2006 | USAO | $337,500,000 | ||
| SunTrust Mortgage Inc. | Truist Financial | financial services | mortgage abuses | 2014 | DOJ_CIVIL | $320,000,000 |
| UniCredit Bank AG | UniCredit | financial services | economic sanction violation | 2019 | NY-MANDA | $316,000,000 |
| ING Bank, NV | ING | financial services | economic sanction violation | 2012 | NY-MANDA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $309,500,000 |
| Quest Diagnostics Incorporated | Quest Diagnostics | healthcare services | False Claims Act and related | 2009 | DOJ_CIVIL | $302,000,000 |
| British Airways PLC | International Airlines Group | airlines | price-fixing or anti-competitive practices | 2007 | DOJ_ANTITRUST | $300,000,000 |
| Korean Air Lines Co. Ltd. | Hanjin Group | diversified | price-fixing or anti-competitive practices | 2007 | DOJ_ANTITRUST | $300,000,000 |
| Samsung Electronics Company Ltd. | Samsung | diversified | price-fixing or anti-competitive practices | 2005 | DOJ_ANTITRUST | $300,000,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | fraud | 2005 | USAO | $300,000,000 |
| Barclays Bank PLC | Barclays | financial services | economic sanction violation | 2010 | DOJ_CRIMINAL | $298,000,000 |
| Standard Chartered Bank | Standard Chartered | financial services | economic sanction violation | 2019 | DOJ_CRIMINAL | $292,210,160 |
| Standard Chartered Bank | Standard Chartered | financial services | economic sanction violation | 2019 | NY-MANDA | $292,000,000 |
| Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
| Bank Leumi Group | Bank Leumi | financial services | tax violations | 2014 | DOJ_TAX | $270,000,000 |
| Credit Suisse AG | UBS | financial services | economic sanction violation | 2009 | DOJ_CRIMINAL | $268,000,000 |
| Credit Suisse AG | UBS | financial services | economic sanction violation | 2009 | NY-MANDA | $268,000,000 |
| AmerisourceBergen Specialty Group | AmerisourceBergen | wholesalers | drug or medical equipment safety violation | 2017 | USAO | $260,000,000 |
| Schlumberger Oilfield Holdings | Schlumberger | oilfield services and supplies | economic sanction violation | 2015 | OFAC | $232,708,356 |
| JPMorgan Chase & Co. | JPMorgan Chase | financial services | price-fixing or anti-competitive practices | 2011 | DOJ_ANTITRUST | $228,000,000 |
| Standard Chartered Bank | Standard Chartered | financial services | economic sanction violation | 2012 | DOJ_CRIMINAL | $227,000,000 |
| Computer Associates International, Inc. | Broadcom | electrical and electronic equipment | accounting fraud or deficiencies | 2004 | USAO | $225,000,000 |
| Chi Mei Optoelectronics | Chi Mei Corporation | chemicals | price-fixing or anti-competitive practices | 2009 | DOJ_ANTITRUST | $220,000,000 |
| BSI SA | tax violations | 2015 | DOJ_TAX | $211,000,000 | ||
| Devos Ltd. dba Guaranteed Returns | fraud | 2019 | USAO | $210,085,535 | ||
| America Online | Apollo Global Management | private equity (including portfolio companies) | accounting fraud or deficiencies | 2004 | DOJ_CRIMINAL | $210,000,000 |
| Elan Corporation PLC | Perrigo | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $203,000,000 |
| Furukawa Electric Co. Ltd. | Furukawa Electric | electrical and electronic equipment | price-fixing or anti-competitive practices | 2011 | DOJ_ANTITRUST | $200,000,000 |
| AEM Inc., Hoth Holdings and Mirabilis Ventures | fraud | 2010 | USAO | $200,000,000 | ||
| Commonwealth Edison Company | Exelon | utilities and power generation | kickbacks and bribery | 2020 | USAO | $200,000,000 |
| Hitachi Automotive Systems Ltd. | Hitachi | diversified | price-fixing or anti-competitive practices | 2013 | DOJ_ANTITRUST | $195,000,000 |
| Mizrahi-Tefahot Bank Ltd. | tax violations | 2019 | USAO | $195,000,000 | ||
| Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $195,000,000 |
| Endo Health Solutions Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | FDA | $192,700,000 |
| HSBC Private Bank (Suisse) SA | HSBC | financial services | tax violations | 2019 | USAO | $192,350,000 |
| Mitsubishi Electric Corporation | Mitsubishi Electric | electrical and electronic equipment | price-fixing or anti-competitive practices | 2013 | DOJ_ANTITRUST | $190,000,000 |
| HSBC Holdings plc | HSBC | financial services | economic sanction violation | 2012 | NY-MANDA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,500,000 |
| Union Bancaire Privee | Union Bancaire Privee | financial services | tax violations | 2016 | DOJ_TAX | $187,000,000 |
| Hynix Semiconductor Inc. | SK Hynix | electrical and electronic equipment | price-fixing or anti-competitive practices | 2005 | DOJ_ANTITRUST | $185,000,000 |
| Lloyds TSB Bank PLC | Lloyds Banking Group | financial services | economic sanction violation | 2009 | DOJ_CRIMINAL | $175,000,000 |
| Lloyds TSB Bank plc | Lloyds Banking Group | financial services | economic sanction violation | 2009 | NY-MANDA | $175,000,000 |
| Commerzbank AG | Commerzbank | financial services | economic sanction violation | 2015 | NY-MANDA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $171,000,000 |
| Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $164,000,000 |
| Societe Generale | Societe Generale | financial services | economic sanction violation | 2018 | NY-MANDA | $162,800,000 |
| UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2011 | DOJ_ANTITRUST | $160,000,000 |
| Infineon Technologies AG | Infineon Technologies | electrical and electronic equipment | price-fixing or anti-competitive practices | 2004 | DOJ_ANTITRUST | $160,000,000 |
| Credit Agricole Corporate and Investment Bank (CACIB) | Credit Agricole | financial services | economic sanction violation | 2015 | USAO | $156,000,000 |
| Credit Agricole Corporate and Investment Bank | Credit Agricole | financial services | economic sanction violation | 2015 | NY-MANDA | $156,000,000 |
| Morgan Stanley & Co. LLC | Morgan Stanley | financial services | investor protection violation | 2024 | USAO | $153,431,223 |
| Barclays plc | Barclays | financial services | economic sanction violation | 2010 | NY-MANDA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $149,000,000 |
| Wachovia Bank N.A. | Wells Fargo | financial services | price-fixing or anti-competitive practices | 2011 | DOJ_ANTITRUST | $148,000,000 |
| Symbol Technologies Inc. | Zebra Technologies | electrical and electronic equipment | fraud | 2004 | USAO | $139,000,000 |
| Bank of America | Bank of America | financial services | price-fixing or anti-competitive practices | 2010 | DOJ_ANTITRUST | $137,300,000 |
| NETeller PLC | gambling violation | 2007 | USAO | $136,000,000 | ||
| Mitsuba Corporation | Mitsuba | automotive parts | price-fixing or anti-competitive practices | 2013 | DOJ_ANTITRUST | $135,000,000 |
| Mitsubishi Corporation | Mitsubishi Corporation | diversified | price-fixing or anti-competitive practices | 2001 | DOJ_ANTITRUST | $134,000,000 |
| Nishikawa Rubber Co. Ltd. | Nishikawa Rubber | automotive parts | price-fixing or anti-competitive practices | 2016 | DOJ_ANTITRUST | $130,000,000 |
| Warner Chilcott PLC | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | FDA | $125,000,000 |
